Scopri i momenti salienti delle Riunioni e Conferenze Annuali del 2019, con approfondimenti e discussioni, tutto reso possibile grazie al supporto di Boehringer Ingelheim Pharmaceuticals.
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins • Oct 25, 2019
Charts
This show is not currently ranked in any charts.
Episodi recenti
Oct 25, 2019
Current Perspective on Antifibrotic Therapy for Patients with IPF
2 mins
Oct 25, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial)
2 mins
Oct 25, 2019
Goals of Care Across the Disease Continuum in IPF
3 mins
Oct 25, 2019
Emerging Diagnostic Approaches to Patients with ILD
6 mins
Oct 25, 2019
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
2 mins
Lingua
Inglese
Paese
Stati Uniti
Categorie
Sito web
Feed
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.